1. ScholarBank@NUS

Huynh The Hung

rp01921

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Huynh The Hung
(not current staff)
Variants
Huynh, H
Huynh, H.
 
Main Affiliation
 
Faculty
 
Email
phchth@nus.edu.sg
 

Publications

Results 1-19 of 19 (Search time: 0.017 seconds).

Issue DateTitleAuthor(s)
125-Mar-2020A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinomaKong, Li Ren ; Salleh, Nur Afiqah Binte Mohamed ; Ong, Richard Weijie; Tan, Tuan Zea ; Syn, Nicholas L; Goh, Robby Miguel; Fhu, Chee Wei ; Tan, Daniel SW ; Iyer, N Gopalakrishna ; Kannan, Srinivasaraghavan; Verma, Chandra S ; Lim, Yaw Chyn ; Soo, Ross ; Ho, Jingshan ; Huang, Yiqing; Lim, Joline SJ ; Yan, Benedict Junrong; Nga, Min En ; Lim, Seng Gee ; Koeffler, H Phillip ; Lee, Soo Chin ; Kappei, Dennis ; Hung, Huynh The ; Goh, Boon Cher 
22017Action of YM155 on clear cell renal cell carcinoma does not depend on surviving expression levelsSim M.Y.; Huynh H. ; Go M.L. ; Yuen J.S.P. 
32015Antitumor activity of the multikinase inhibitor regorafenib in patient-derived xenograft models of gastric cancerHuynh, H ; Ong, R; Zopf, D
42007AZD6244 and doxorubicin induce growth suppression and apoptosis in mouse models of hepatocellular carcinomaHuynh, H ; Chow, P.K.H ; Soo, K.-C
52010AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)Huynh, H ; Ngo, V.C.; Soo, K.C. ; Koong, H.N. ; Poon, D.; Choo, S.P.; Toh, H.C. ; Thng, C.H.; Chow, P.; Ong, H.S. ; Chung, A.; Goh, B.C. ; Smith, P.D.
66Jul-2017Belinostat exerts antitumor cytotoxicity through the ubiquitin-proteasome pathway in lung squamous cell carcinomaKong, L.R ; Tan, T.Z ; Ong, W.R; Bi, C; Huynh, H ; Lee, S.C ; Chng, W.J ; Eichhorn, P.J.A ; Goh, B.C 
672008Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinomaHuynh, H. ; Yu, K.; Wu, J.; Lee, M.H.; Hor, H.; Soo, K.C. ; Toh, H.C. ; Tan, P. ; Salto-Tellez, M. ; Chow, P.K.H. ; Lee, C.K.; Soong, R. ; Goh, B.C. ; Lee, H.S. ; Somani, A.; Tan, P.H. ; Palanisamy, N.; Kalpana, R.
682008Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinomaHuynh, H ; Ngo, V.C; Fargnoli, J; Ayers, M; Khee, C.S; Heng, N.K; Choon, H.T; Hock, S.O; Chung, A ; Chow, P ; Pollock, P; Byron, S; Tran, E
92012Combination of the ERK inhibitor AZD6244 and low-dose sorafenib in a xenograft model of human renal cell carcinomaYuen, J.S.P ; Sim, M.Y; Sim, H.G ; Chong, T.W ; Lau, W.K.O ; Cheng, C.W.S ; Ong, R.W; Huynh, H 
102015Combinatorial treatment using targeted MEK and SRC inhibitors synergistically abrogates tumor cell growth and induces mesenchymal-epithelial transition in non-small-cell lung carcinomaChua, K.N ; Kong, L.R ; Sim, W.J ; Ng, H.C; Ong, W.R; Thiery, J.P ; Huynh, H ; Goh, B.C 
119-Sep-2020Dynamic Contrast-Enhanced Magnetic Resonance Imaging as Imaging Biomarker for Vascular Normalization Effect of Infigratinib in High-FGFR-Expressing Hepatocellular Carcinoma XenograftsHuynh The Hung 
121-Jan-2023FAM3C in circulating tumor-derived extracellular vesicles promotes non-small cell lung cancer growth in secondary sitesThuya, WL ; Kong, LR ; Syn, NL; Ding, LW ; Cheow, ESH ; Wong, RTX ; Wang, T ; Goh, RMWJ; Song, H ; Jayasinghe, MK; Le, MTN; Hu, JC; Yong, WP ; Lee, SC ; Wong, ALA ; Sethi, G ; Hung, HT ; Ho, PCL ; Thiery, JP ; Sze, SK ; Guo, T; Soo, RA ; Yang, H; Lim, YC ; Wang, L ; Goh, BC 
132002Fibroblasts cocultured with keloid keratinocytes: Normal fibroblasts secrete collagen in a keloidlike mannerLim, I.J. ; Phan, T.-T. ; Longaker, M.T.; Bay, B.-H. ; Qi, R. ; Huynh, H. ; Lee, S.-T.; Tan, W.T.-L. 
142017Human mesenchymal stem cells preferentially migrate toward highly oncogenic human hepatocellular carcinoma cells with activated EpCAM signalingEndaya B ; Guan S.P. ; Newman J.P.; Huynh H. ; Sia K.C.; Chong S.T.; Kok C.Y.L.; Chung A.Y.F. ; Liu B.B.; Hui K.M.; Lam P.Y.P. 
151-Jul-2015MEK Inhibition Overcomes Cisplatin Resistance Conferred by SOS/MAPK Pathway Activation in Squamous Cell CarcinomaKong, Li Ren ; Chua, Kian Ngiap ; Sim, Wen Jing ; Ng, Hsien Chun ; Bi, Chonglei; Ho, Jingshan ; Nga, Min En ; Pang, Yin Huei ; Ong, Weijie Richard; Soo, Ross Andrew ; Huynh, The Hung ; Chng, Wee Joo ; Thiery, Jean-Paul ; Goh, Boon Cher 
1626-Sep-2018Mitochondrial uncoupling reveals a novel therapeutic opportunity for p53-defective cancersKumar, R ; Coronel, L; Somalanka, B; Raju, A; Aning, OA; An, O ; Ho, YS; Chen, S; Mak, SY; Hor, PY; Yang, H ; Lakshmanan, M ; Itoh, H; Tan, SY ; Lim, YK ; Wong, APC ; Chew, SH; Huynh, TH ; Goh, BC ; Lim, CY ; Tergaonkar, V ; Cheok, CF 
172003Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: Its role in tumor progression and apoptosisHuynh H. ; Tuyen Nguyen T.T.; Pierce Chow K.-H. ; Tan P.H. ; Soo K.C. ; Tran E.
188-Feb-2007Silencing expression of UO-44 (CUZD1) using small interfering RNA sensitizes human ovarian cancer cells to cisplatin in vitroLeong, C.T.C.; Ong, C.K.; Tay, S.K.; Huynh, H. 
1931-Jul-2021Targeted Inhibition of FGF19/FGFR Cascade Improves Anti-Tumor Immunity and Response Rate in Hepatocellular CarcinomaHuynh The Hung